4.7 Article

Altered signaling in systemic juvenile idiopathic arthritis monocytes

Journal

CLINICAL IMMUNOLOGY
Volume 163, Issue -, Pages 66-74

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.clim.2015.12.011

Keywords

Juvenile arthritis; Monocytes; IFN signaling; SOCS1

Categories

Funding

  1. Wasie Foundation
  2. Dana Foundation
  3. Child Health Research Program of Stanford University
  4. National Institutes of Health [NIH R01AR061297]
  5. Becton Dickinson Immunology Grant
  6. Thrasher Foundation

Ask authors/readers for more resources

Systemic juvenile idiopathic arthritis (sJIA) is characterized by systemic inflammation anti arthritis. Monocytes are implicated in sJIA pathogenesis, but their role in disease is unclear. The response of sJIA monocytes to IFN may be dysregulated. We examined intracellular signaling in response to IFN type I (IFN alpha) and type II (IFN gamma) in monocytes during sJIA activity and quiescence, in 2 patient groups. Independent of disease activity, monocytes from Group 1 (collected between 2002 and 2009) showed defective STAT1 phosphorylation downstream of IFNs, and expressed higher transcript levels of SOCS1, an, inhibitor of IFN signaling. In the Group 2 (collected between 2011 and 2014), monocytes of patients with recent disease onset were IFN gamma hyporesponsive, but in treated, quiescent subjects, monocytes were hyperresponsive to IFN gamma. Recent changes in medication in sJIA may alter the IFN hyporesponsiveness. Impaired IFN/pSTAT1 signaling is consistent with skewing of sJIA monocytes away from an M1 phenotype and may contribute to disease Pathology. (C) 2015 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available